NO20052291D0 - Nye bicyklsike inhibitorer av hormonsensitiv lipase - Google Patents

Nye bicyklsike inhibitorer av hormonsensitiv lipase

Info

Publication number
NO20052291D0
NO20052291D0 NO20052291A NO20052291A NO20052291D0 NO 20052291 D0 NO20052291 D0 NO 20052291D0 NO 20052291 A NO20052291 A NO 20052291A NO 20052291 A NO20052291 A NO 20052291A NO 20052291 D0 NO20052291 D0 NO 20052291D0
Authority
NO
Norway
Prior art keywords
hormone
sensitive lipase
novel bicyclic
bicyclic inhibitors
inhibitors
Prior art date
Application number
NO20052291A
Other languages
English (en)
Norwegian (no)
Other versions
NO20052291L (no
Inventor
Guenter Mueller
Hubert Heuer
Karl-Heinz Baringhaus
Stefan Petry
Norbert Nagels
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20052291D0 publication Critical patent/NO20052291D0/no
Publication of NO20052291L publication Critical patent/NO20052291L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20052291A 2002-10-12 2005-05-10 Nye bicyklsike inhibitorer av hormonsensitiv lipase NO20052291L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10247680A DE10247680B4 (de) 2002-10-12 2002-10-12 Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase
PCT/EP2003/010765 WO2004035550A1 (de) 2002-10-12 2003-09-27 Neue bicyclische inhibitoren der hormon sensitiven lipase

Publications (2)

Publication Number Publication Date
NO20052291D0 true NO20052291D0 (no) 2005-05-10
NO20052291L NO20052291L (no) 2005-05-10

Family

ID=32038583

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052291A NO20052291L (no) 2002-10-12 2005-05-10 Nye bicyklsike inhibitorer av hormonsensitiv lipase

Country Status (39)

Country Link
EP (1) EP1554259B1 (es)
JP (2) JP4658607B2 (es)
KR (1) KR20050059254A (es)
CN (1) CN100366616C (es)
AR (1) AR041565A1 (es)
AT (1) ATE349433T1 (es)
AU (1) AU2003275997B8 (es)
BR (1) BR0315257A (es)
CA (1) CA2501734C (es)
CR (1) CR7717A (es)
CY (1) CY1106358T1 (es)
DE (2) DE10247680B4 (es)
DK (1) DK1554259T3 (es)
EC (1) ECSP055729A (es)
ES (1) ES2277152T3 (es)
GT (1) GT200300214A (es)
HK (1) HK1080473A1 (es)
HN (1) HN2003000316A (es)
HR (1) HRP20050325A2 (es)
IL (1) IL167907A (es)
JO (1) JO2497B1 (es)
MA (1) MA27404A1 (es)
MX (1) MXPA05003359A (es)
MY (1) MY138057A (es)
NO (1) NO20052291L (es)
OA (1) OA12941A (es)
PA (1) PA8585101A1 (es)
PE (1) PE20040776A1 (es)
PL (1) PL374605A1 (es)
PT (1) PT1554259E (es)
RS (1) RS51543B (es)
RU (1) RU2325385C2 (es)
SV (1) SV2004001633A (es)
TN (1) TNSN05105A1 (es)
TW (1) TWI313265B (es)
UA (1) UA79994C2 (es)
UY (1) UY28015A1 (es)
WO (1) WO2004035550A1 (es)
ZA (1) ZA200501757B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005002130A1 (de) 2005-01-17 2006-07-27 Sanofi-Aventis Deutschland Gmbh Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel
DE102005026808A1 (de) 2005-06-09 2006-12-14 Sanofi-Aventis Deutschland Gmbh Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005026809A1 (de) 2005-06-09 2006-12-14 Sanofi-Aventis Deutschland Gmbh Benzothiazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005048897A1 (de) 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005049954A1 (de) 2005-10-19 2007-05-31 Sanofi-Aventis Deutschland Gmbh Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005049953A1 (de) 2005-10-19 2007-04-26 Sanofi-Aventis Deutschland Gmbh Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen
FR2915198B1 (fr) * 2007-04-18 2009-12-18 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
FR2915199B1 (fr) * 2007-04-18 2010-01-22 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique.
FR2915197B1 (fr) 2007-04-18 2009-06-12 Sanofi Aventis Sa Derives de triazolopyridine-carboxamides, leur preparation et leur application therapeutique.
UY31968A (es) 2008-07-09 2010-01-29 Sanofi Aventis Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
BR122013027950A2 (pt) * 2008-12-24 2019-12-10 BIAL PORTELA & Cª S A compostos farmacêuticos
US8329904B2 (en) * 2009-05-12 2012-12-11 Hoffmann-La Roche Inc. Azacyclic derivatives
US8440710B2 (en) * 2009-10-15 2013-05-14 Hoffmann-La Roche Inc. HSL inhibitors useful in the treatment of diabetes
US8097634B2 (en) 2010-04-15 2012-01-17 Hoffmann-La Roche Inc. Azacyclic derivatives
US8450350B2 (en) * 2010-05-05 2013-05-28 Infinity Pharmaceuticals, Inc. Triazoles as inhibitors of fatty acid synthase
US8722721B2 (en) * 2011-03-16 2014-05-13 Hoffmann-La Roche Inc. SEC-hydroxycyclohexyl derivatives
US8703807B2 (en) * 2011-03-17 2014-04-22 Hoffmann-La Roche Inc. Azaspirodecanone compounds
US8809384B2 (en) * 2011-03-25 2014-08-19 Hoffmann-La Roche Inc. Azaspirodecanone compounds
UA119247C2 (uk) 2013-09-06 2019-05-27 РОЙВЕНТ САЙЕНСИЗ ҐмбГ Спіроциклічні сполуки як інгібітори триптофангідроксилази
GB201321740D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
WO2015089137A1 (en) 2013-12-11 2015-06-18 Karos Pharmaceuticals, Inc. Acylguanidines as tryptophan hydroxylase inhibitors
WO2016109501A1 (en) 2014-12-30 2016-07-07 Karos Pharmaceuticals, Inc. Amide compounds as tryptophan hydroxylase inhibitors
US9611201B2 (en) 2015-03-05 2017-04-04 Karos Pharmaceuticals, Inc. Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone
KR20210102887A (ko) 2018-11-14 2021-08-20 알타반트 사이언시스 게엠베하 말초 세로토닌과 관련된 질병 또는 장애를 치료하기 위한 트립토판 하이드록실라제 1 (tph1)의 결정질 스피로사이클릭 화합물 억제제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1126999A (en) * 1978-10-20 1982-07-06 Michael J. Simons Use of azole compounds with a n,n disubstituted carbamoyl group on a ring nitrogen as development restrainer precursors in photographic elements
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
US7432270B2 (en) * 2001-05-05 2008-10-07 Smithkline Beecham P.L.C. N-aroyl cyclic amines
US7067517B2 (en) * 2001-12-14 2006-06-27 Nero Nordisk A/S Use of compounds for decreasing activity of hormone-sensitive lipase

Also Published As

Publication number Publication date
EP1554259B1 (de) 2006-12-27
DE50306134D1 (de) 2007-02-08
TWI313265B (en) 2009-08-11
DE10247680A1 (de) 2004-04-22
RS51543B (en) 2011-06-30
HN2003000316A (es) 2006-06-12
CA2501734A1 (en) 2004-04-29
MA27404A1 (fr) 2005-06-01
ES2277152T3 (es) 2007-07-01
MY138057A (en) 2009-04-30
AR041565A1 (es) 2005-05-18
HRP20050325A2 (en) 2005-06-30
BR0315257A (pt) 2005-08-23
ZA200501757B (en) 2005-09-07
TNSN05105A1 (en) 2007-05-14
CN1688555A (zh) 2005-10-26
PA8585101A1 (es) 2004-09-16
CN100366616C (zh) 2008-02-06
CY1106358T1 (el) 2011-10-12
CR7717A (es) 2007-09-14
MXPA05003359A (es) 2005-06-22
DE10247680B4 (de) 2005-09-01
RU2005114394A (ru) 2006-01-20
UY28015A1 (es) 2004-04-30
PL374605A1 (en) 2005-10-31
IL167907A (en) 2010-12-30
HK1080473A1 (en) 2006-04-28
CA2501734C (en) 2011-05-31
KR20050059254A (ko) 2005-06-17
PE20040776A1 (es) 2004-12-24
AU2003275997A1 (en) 2004-05-04
PT1554259E (pt) 2007-02-28
GT200300214A (es) 2007-02-05
JP2006509734A (ja) 2006-03-23
TW200413335A (en) 2004-08-01
AU2003275997B8 (en) 2010-09-30
SV2004001633A (es) 2004-03-19
NO20052291L (no) 2005-05-10
WO2004035550A1 (de) 2004-04-29
UA79994C2 (en) 2007-08-10
ECSP055729A (es) 2005-07-06
ATE349433T1 (de) 2007-01-15
DK1554259T3 (da) 2007-05-07
RU2325385C2 (ru) 2008-05-27
JP2011026342A (ja) 2011-02-10
JP4658607B2 (ja) 2011-03-23
RS20050207A (en) 2007-08-03
JO2497B1 (en) 2009-10-05
EP1554259A1 (de) 2005-07-20
OA12941A (en) 2006-10-13
AU2003275997B2 (en) 2010-03-25

Similar Documents

Publication Publication Date Title
NO20052291D0 (no) Nye bicyklsike inhibitorer av hormonsensitiv lipase
NO20050072L (no) Nye inhibitorer av kinaser
NO20050636L (no) Inhibitorer av tyrosinkinaser
NO20045220L (no) Heterocykliske inhibitorer for kinaser
NO20043695L (no) Selektive dipeptidinhibitorer av kallikrein
NO20050118D0 (no) Substituerte fenylsulfonamidinhibitorer av beta-amyolid produksjon
NO20050563L (no) N-aryl-piperidinsubstituerte bifenylkarboksamider som inhibitorer av apolipoprotein B-sekresjon
DE502005011241D1 (de) Indazolderivate als inhibitoren der hormon-sensitiven lipase
AU2003215112A8 (en) Novel bicyclic hydroxamates as inhibitors of histone deacetylase
NO20055714D0 (no) Inhibitorer av fosfatidylinositol 3-kinase
SE530720E (sv) Förbehandling av flis med höggradig defibrering
NO20052348D0 (no) Behandling av hemoragisk sjokk
PT1562589E (pt) Diaminotriazoles úteis como inibidores de proteína-quinases
HK1077762A1 (zh) TFGß[轉化生長因子]的抑制劑
ATE382048T1 (de) Pyrazolopyrimdine als hemmstoffe cyclin abhängiger kinasen
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
ATE499096T1 (de) Kombination von serotonin-wiederaufnahme-hemmern und agomelatin
AU2003265239A1 (en) Protective effects of pde-5 inhibitors
AU2003295638A8 (en) Novel inhibitors of beta-lactamase
NO20031320D0 (no) System for klassifisering av havbunnsujevnhet
EP1542682A4 (en) NEW HEMMER OF UBIQUITINE ISOPEPTIDASES
SI1554259T1 (sl) Novi biciklicni inhibitorji hormonsko senzitivne lipaze
ZA200500492B (en) Novel inhibitors of kinases
GB0204088D0 (en) Novel substituted heterocyclic inhibitors of catechol-o-methyl transperase

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application